CCTx-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCTx-001, covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia [Phase 1, Phase 2]